This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Defines the base value in index calculation and explains its role as the reference point for all subsequent index levels.
21,618 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
As Uniti maps out its path for 2026, investors want clarity on revenue, cash flow, and growth prospects. This guide b...
CrowdStrike stock just 52-week highs signal strong momentum, but investors must weigh the run-up against real growth....
A major AI and cloud deal is flanking SpaceX's IPO, potentially nudging investor sentiment. This article breaks down ...
Micron Technology rides the AI memory wave, but a blowout earnings report invites questions. This guide breaks down t...
Vodafone Group shares jumped about 13% after a dramatic stake reshuffle that makes Vega the largest shareholder. The ...
Headwinds have pressured Vornado, but two strategic catalysts could unlock meaningful upside. This guide breaks down ...
A major fund recently disclosed a sizable bet on The Andersons, flashing confidence in the agribusiness sector. This ...
FRP Holdings delivered a resilient Q3 2024 performance across its diversified subsidiaries. This deep dive reviews th...
Nvidia and Alphabet are leading a new era of high-growth tech. This deep dive breaks down why each company could reac...
Nebius stock skyrocketed more, driven by demand for AI infrastructure. This guide breaks down the drivers, the number...
Remitly is reshaping how money moves across borders. This investing guide breaks down the disruption, how to evaluate...